Haleon has completed a deal to boost its stake in its Chinese OTC joint venture, Tianjin TSKF Pharmaceutical.
Haleon Completes Deal To Grow Stake In China JV
Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.
More from Deals
More from Geography
• By
Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.
• By
Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”
• By
HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.